⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer

Kankan Cao Guodong Zhang Moran Yang Yiying Wang Mengdi He Chen Zhang Yan Huang Jiaqi Lu Haiou Liu

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary Tables S1 to S9 for multiple supplementary tables

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cao et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587523360 https://doi.org/10.1158/0008-5472.27027782.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024
2Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024
3Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024
4Supplementary Data from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy2024
5Supplementary Data from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy2024

More related papers

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance2024
Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance2024
Supplementary Data from Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors2024